Market Expansion:
Public materials indicate the platform footprint has grown to 6,000+ research sites and 25+ sponsors, up from 5,500+ sites cited in late 2025, suggesting continued expansion into 2026. Geographic reach and site participation are portrayed as broadening across dozens of countries.
Strategic Partnerships:
Collaborations with large biopharma (e.g., Sanofi, including a 2026 portfolio-level discussion) and integrations with ecosystem vendors like CRIO, RealTime-Devana, and eClinPro signal commercial traction and deeper ecosystem ties. These relationships are positioned to increase marketplace activity and data depth for sponsors and sites.
Innovation-Driven Growth:
AI-powered pre-screening and workflow tooling launched in 2025 with ongoing case studies and integrations in 2026, aimed at accelerating enrollment and reducing site burden. The continued rollout of AI features and workflow enhancements suggests rising product maturity and adoption.
